Using Hsp90 inhibitors in the clinic: what have we learned?

Share :
Published: 10 Mar 2015
Views: 4405
Rating:
Save
Dr Udai Banerji - Institute of Cancer Research, Sutton, United Kingdom

Heat shock protein (Hsp) 90 is a ubiquitous protein that helps other proteins to fold and stabilises a number of proteins involved in tumour growth.

Dr Banjerji talks to ecancertv at TAT 2015 about his experience with Hsp90 inhibitors and the practicalities of using these drugs in the clinic.